SEC Tracker
Get the app

Rhythm Pharmaceuticals RYTM

Rhythm Pharmaceuticals: quarterly report for the quarter ended Sep 30, 2023

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Rhythm Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Vaxcyte PCVX public float $3.7B, Jun 30, 2025
  2. Dynavax Technologies DVAX
  3. PERRIGO PRGO public float $3.7B, Jun 27, 2025
  4. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025
  5. Adma Biologics ADMA public float $4.2B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.